Targeted Therapy for Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Featuring perspectives from Drs Zofia Piotrowska and Gregory Riely, including the following topics:

• Introduction: What Is Targeted Therapy? (0:00)
• EGFR-Activating Mutations (12:23)
• EGFR Exon 20 Insertion Mutations (27:54)
• ALK and ROS1 Rearrangements (31:31)
• HER2 Mutations (36:17)
• NRG1 Fusions (45:39)
• RET Fusions (49:07)
• MET Exon 14 Mutations (53:10)
• KRAS G12C Mutations (56:01)

CME information and select publications